biomea fusion
Terrie Phan has extensive work experience across various roles and companies. Terrie is currently serving as the VP, Corporate Controller at Biomea Fusion since July 2021. Prior to this, they worked as the Corporate Controller at IGM Biosciences, Inc. from August 2019 to June 2021. Terrie also held roles at Pulse Biosciences, Inc., including Controller from August 2018 to August 2019 and Assistant Controller from January 2018 to July 2018. Additionally, Terrie worked at Pharmacyclics as the Associate Director of FP&A from May 2016 to January 2018, and as the Associate Director of Accounting from October 2012 to May 2016. Terrie also worked at ZELTIQ as the Technical Accounting Manager from February 2012 to September 2012, and at Symantec as a Senior Internal Auditor from May 2011 to February 2012. Terrie began their career at PricewaterhouseCoopers as a Senior Associate from September 2006 to May 2011, and also interned at Calpine from 2004 to 2005.
Terrie Phan completed a Bachelor of Science degree in Accounting from Santa Clara University Leavey School of Business in the years 2002-2006. Terrie also holds a CPA certification, although the institution and specific year of obtaining it are not provided.
biomea fusion
Biomea Fusion, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of irreversible small molecules to treat patients with genetically defined cancers. The company was formed in 2017 by a small group of biotech executives that came together with the common goal of achieving better therapies for patients.